Cue Biopharma, Inc. (CUE) News
Track canonical SquawkNews coverage tagged to CUE, Cue Biopharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Cue Biopharma reports positive Phase 2 topline results for CUE-221
Cue Biopharma said CUE-221 met dose-responsive primary and secondary endpoints in chronic spontaneous urticaria, with a favorable safety profile and durable benefit versus placebo and omalizumab.
EQUITY | Sep 21, 2026, 12:04 PM UTC
M
Cue Biopharma shares jump premarket on positive urticaria trial results
Cue Biopharma shares rallied ahead of the opening bell after positive results in a trial of a prospective treatment for chronic spontaneous urticaria; premarket, the stock was up 51% to $56.00.
EQUITY | Sep 21, 2026, 10:59 AM UTC
H
Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Shares of Lobo Technologies Ltd (NASDAQ: LOBO ) rose sharply in pre-market trading after the company reported a year-over-year increase in H1 financial results. Lobo EV Technologies posted a H1 loss of 7 cents per share,
LIVE | Sep 21, 2026, 09:01 AM UTC
L
CUE - Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
CUE - Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
NEWS | Sep 20, 2026, 10:01 AM UTC
L
Cue Energy Resources posts FY revenues from operations A$50.2 million
Cue Energy Resources reported FY revenues from operations of A$50.2 million.
EQUITY | Aug 27, 2026, 01:24 AM UTC
L
Cue Biopharma reports Q2 2026 financial results, business highlights
Cue Biopharma reports its second quarter 2026 financial results and recent business highlights; no financial figures, comparisons, or catalysts are provided in the feed.
EARNINGS | Aug 14, 2026, 08:06 PM UTC
L
Multiple companies announce shelf filings and equity, debt offerings
The wire lists several capital-raising actions, including ARE pricing $1,000,000,000 of Series A fixed-to-fixed reset rate junior subordinated notes due 2057 and RHP closing a common stock offering with full over-allotme
MNA | Aug 13, 2026, 10:31 AM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Tuesday's intraday session, with Aditxt and Atlantic International leading the gainers and Trinity Biotech and Tenon Medical leading the losers
EQUITY | Jun 23, 2026, 05:09 PM UTC
M
BIVI Files $300M Mixed Shelf
BIVI and other companies file mixed shelf offerings with the SEC
EQUITY | Jun 22, 2026, 09:29 AM UTC